Ultragenyx Pharmaceutical Inc.
← Back to RARE Overview

Ultragenyx Pharmaceutical Inc. (RARE)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-4.45

Financial Fundamentals

RAREQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2012-12-31-49.41
2013-03-31-36.17
2013-06-30-28.36
2013-09-30-28.90
2013-12-31-24.32
2014-03-31-19.35
2014-06-30-24.83
2014-09-30-28.24
2014-12-31-20.91
2015-03-31-24.69
2015-06-30-30.88
2015-09-30-23.49
2015-12-31-19.74
2016-03-31-11.69
2016-06-30-8.38
2016-09-30-10.81
2016-12-31-10.06
2017-03-31-10.38
2017-06-30-9.02
2017-09-30-7.14
2017-12-31-6.12
2018-03-3120.31
2018-06-30-18.16
2018-09-30-11.01
2018-12-31-6.27
2019-03-31-9.62
2019-06-30-9.11
2019-09-30-5.46
2019-12-31-6.58
2020-03-31-5.41
2020-06-3046.34
2020-09-30-18.11
2020-12-31-93.20
2021-03-31-14.03
2021-06-30-13.16
2021-09-30-20.97
2021-12-31-11.77
2022-03-31-8.29
2022-06-30-6.59
2022-09-30-2.96
2022-12-31-5.35
2023-03-31-4.30
2023-06-30-5.12
2023-09-30-4.00
2023-12-31-7.87
2024-03-31-5.80
2024-06-30-6.76
2024-09-30-9.93
2024-12-31-7.54
2025-03-31-5.77
2025-06-30-7.79
2025-09-30-4.16
2025-12-31-4.45

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.